Impact of the COAPT Trial on Heart Failure Patients With Functional Mitral Regurgitation

Andreas Brieke, M.D., director of mechanical circulatory support, heart failure physician and site principal investigator for the COAPT Trial at the University of Colorado Hospital, explains the impact of that study on the care of heart failure patients with functional mitral regurgitation. The trial used the MitraClip to treat patients with functional MR and showed it had a major impact on patient quality of life and heart function, offering a paradigm shift in care. Read the article "MitraClip Reduces Mortality for Heart Failure Patients With Secondary Mitral Regurgitation." - https://www.dicardiology.com/content/... Watch the VIDEO: MitraClip to Treat Heart Failure — Results of the COAPT Trial, an interview with William Abraham, M.D. — https://www.dicardiology.com/videos/v...